Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Post, Robert M.
2015.
Relative absence of studies in bipolar depression.
International Clinical Psychopharmacology,
Vol. 30,
Issue. 5,
p.
239.
Glue, Paul
and
Herbison, Peter
2015.
Comparative efficacy and acceptability of combined antipsychotics and mood stabilizers versus individual drug classes for acute mania: Network meta-analysis.
Australian & New Zealand Journal of Psychiatry,
Vol. 49,
Issue. 12,
p.
1215.
Fountoulakis, Kostas N.
2015.
Bipolar Disorder.
p.
461.
Grande, Iria
and
Vieta, Eduard
2015.
Pharmacotherapy of Acute Mania: Monotherapy or Combination Therapy with Mood Stabilizers and Antipsychotics?.
CNS Drugs,
Vol. 29,
Issue. 3,
p.
221.
Lao, Kim S. J.
He, Ying
Wong, Ian C. K.
Besag, Frank M. C.
and
Chan, Esther W.
2016.
Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials.
CNS Drugs,
Vol. 30,
Issue. 11,
p.
1043.
Fountoulakis, Konstantinos N.
Yatham, Lakshmi
Grunze, Heinz
Vieta, Eduard
Young, Allan
Blier, Pierre
Kasper, Siegfried
and
Moeller, Hans Jurgen
2016.
The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.
International Journal of Neuropsychopharmacology,
p.
pyw100.
Grande, Iria
Berk, Michael
Birmaher, Boris
and
Vieta, Eduard
2016.
Bipolar disorder.
The Lancet,
Vol. 387,
Issue. 10027,
p.
1561.
Harrison, Paul J.
Cipriani, Andrea
Harmer, Catherine J.
Nobre, Anna C.
Saunders, Kate
Goodwin, Guy M.
and
Geddes, John R.
2016.
Innovative approaches to bipolar disorder and its treatment.
Annals of the New York Academy of Sciences,
Vol. 1366,
Issue. 1,
p.
76.
Cipriani, A
Saunders, K
Attenburrow, M-J
Stefaniak, J
Panchal, P
Stockton, S
Lane, T A
Tunbridge, E M
Geddes, J R
and
Harrison, P J
2016.
A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development.
Molecular Psychiatry,
Vol. 21,
Issue. 10,
p.
1324.
Smith, Katharine A.
Cipriani, Andrea
and
Geddes, John R.
2016.
The usefulness and interpretation of systematic reviews.
BJPsych Advances,
Vol. 22,
Issue. 2,
p.
132.
Goodwin, GM
Haddad, PM
Ferrier, IN
Aronson, JK
Barnes, TRH
Cipriani, A
Coghill, DR
Fazel, S
Geddes, JR
Grunze, H
Holmes, EA
Howes, O
Hudson, S
Hunt, N
Jones, I
Macmillan, IC
McAllister-Williams, H
Miklowitz, DR
Morriss, R
Munafò, M
Paton, C
Sahakian, BJ
Saunders, KEA
Sinclair, JMA
Taylor, D
Vieta, E
and
Young, AH
2016.
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology.
Journal of Psychopharmacology,
Vol. 30,
Issue. 6,
p.
495.
Kanzawa, Mark
and
Hadden, Olga
2017.
Case report of a switch to mania induced by lurasidone.
Therapeutic Advances in Psychopharmacology,
Vol. 7,
Issue. 2,
p.
91.
Murray, Robin
Correll, Christoph U.
Reynolds, Gavin P.
and
Taylor, David
2017.
Atypical antipsychotics: recent research findings and applications to clinical practice: Proceedings of a symposium presented at the 29th Annual European College of Neuropsychopharmacology Congress, 19 September 2016, Vienna, Austria.
Therapeutic Advances in Psychopharmacology,
Vol. 7,
Issue. 1_suppl,
p.
1.
Li, Dian-Jeng
Tseng, Ping-Tao
Stubbs, Brendon
Chu, Che-Sheng
Chang, Han-Yung
Vieta, Eduard
Fornaro, Michele
Carvalho, Andre F.
Solmi, Marco
Veronese, Nicola
Chen, Tien-Yu
Chen, Yen-Wen
Lin, Pao-Yen
and
Chow, Philip Chik-keung
2017.
Efficacy, safety and tolerability of aripiprazole in bipolar disorder: An updated systematic review and meta-analysis of randomized controlled trials.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 79,
Issue. ,
p.
289.
Samara, Myrto T
Goldberg, Yair
Levine, Stephen Z
Furukawa, Toshi A
Geddes, John R
Cipriani, Andrea
Davis, John M
and
Leucht, Stefan
2017.
Initial symptom severity of bipolar I disorder and the efficacy of olanzapine: a meta-analysis of individual participant data from five placebo-controlled studies.
The Lancet Psychiatry,
Vol. 4,
Issue. 11,
p.
859.
Undurraga, Juan
and
Baldessarini, Ross J
2017.
Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-to-head trials in acute major depression: Systematic review and meta-analysis.
Journal of Psychopharmacology,
Vol. 31,
Issue. 9,
p.
1184.
Paulzen, M.
Gründer, G.
and
Benkert, O.
2017.
Kompendium der Psychiatrischen Pharmakotherapie.
p.
201.
Sigitova, Ekaterina
Fišar, Zdeněk
Hroudová, Jana
Cikánková, Tereza
and
Raboch, Jiří
2017.
Biological hypotheses and biomarkers of bipolar disorder.
Psychiatry and Clinical Neurosciences,
Vol. 71,
Issue. 2,
p.
77.
Hebbrecht, Kaat
Morrens, Manuel
Neels, Hugo
Roosens, Laurence
and
Sabbe, Bernard G. C.
2018.
Pharmacokinetic evaluation of the aripiprazole (once-monthly) injection for the treatment of bipolar disorder.
Expert Opinion on Drug Metabolism & Toxicology,
Vol. 14,
Issue. 10,
p.
999.
Bartoli, Francesco
Clerici, Massimo
Di Brita, Carmen
Riboldi, Ilaria
Crocamo, Cristina
and
Carrà, Giuseppe
2018.
Effect of clinical response to active drugs and placebo on antipsychotics and mood stabilizers relative efficacy for bipolar depression and mania: A meta-regression analysis.
Journal of Psychopharmacology,
Vol. 32,
Issue. 4,
p.
416.